Related Experiment Video
Updated: Sep 14, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
Perillyl alcohol promotes autophagy by suppressing the PI3K-AKT-mTOR signalling pathway in osteoarthritic
Duo Zhao1, Jiean Nong2, Xiaofeng Li1
1Department of Spine and Osteopathy Surgery, The Second Affiliated Hospital of Guangxi Medical University, Nanning, 530007, Guangxi, China.
Abstract:
Osteoarthritis (OA) is a common degenerative disease characterized by chondrocyte death and extracellular matrix (ECM) degradation, but the present OA treatments are only symptomatic and not aetiologic. Autophagy is a key protective mechanism for OA through the inhibition of chondrocyte apoptosis and degeneration. Perillyl alcohol (POH) is a monomer derived from Chinese herbal medicines that can regulate autophagy and has anti-inflammatory effects. In this study, cell viability, chondrocyte phenotype and the expression of molecules involved in autophagy and the PI3K-AKT-mTOR signalling pathway were detected to explore the hypothesis that POH may decrease the progression of OA by regulating autophagy. We found that POH significantly inhibited the expression of inflammatory cytokines, maintained the chondrocyte phenotype, and protected against ECM degeneration. We also provide evidence that the anti-inflammatory effect of POH works by regulating autophagy via the PI3K-AKT-mTOR signalling pathway. This study demonstrates for the first time that POH has a therapeutic effect on arthritis, which suggests that POH may be a promising candidate for OA therapy.
Insights
Perillyl alcohol (POH), derived from Chinese herbal medicine, shows therapeutic potential for osteoarthritis (OA). POH regulates autophagy via the PI3K-AKT-mTOR pathway, reducing inflammation and protecting against cartilage degeneration.
Area of Science:
- Biochemistry
- Pharmacology
- Cell Biology
Background:
- Osteoarthritis (OA) is a degenerative joint disease marked by chondrocyte death and extracellular matrix (ECM) degradation.
- Current OA treatments offer symptomatic relief but do not address the disease's root causes.
- Autophagy plays a crucial role in OA by inhibiting chondrocyte apoptosis and degeneration.
Purpose of the Study:
- To investigate the therapeutic potential of Perillyl alcohol (POH) in mitigating OA progression.
- To explore the mechanism by which POH regulates autophagy and its impact on the PI3K-AKT-mTOR signaling pathway.
- To evaluate POH's anti-inflammatory effects and its ability to protect chondrocytes and ECM.
Main Methods:
- Assessed cell viability and chondrocyte phenotype.
- Measured the expression of molecules involved in autophagy and the PI3K-AKT-mTOR pathway.
- Quantified inflammatory cytokine expression and ECM integrity.
Main Results:
- POH significantly inhibited the expression of pro-inflammatory cytokines.
- POH treatment maintained chondrocyte phenotype and protected against ECM degeneration.
- Evidence suggests POH's anti-inflammatory effects are mediated by regulating autophagy through the PI3K-AKT-mTOR pathway.
Conclusions:
- POH demonstrates a therapeutic effect on arthritis, suggesting its potential as a novel OA treatment.
- POH's mechanism involves modulating autophagy via the PI3K-AKT-mTOR signaling pathway.
- POH represents a promising candidate for future osteoarthritis therapies.
More Related Videos
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

